Editors:
- Current review of the basic principles of ocular pharmacology, pharmacokinetics, and drug delivery including novel approaches to delivering compounds to the eye like sustained-release implants, cell therapy, and gene therapy
- Review of existing and future therapies for ocular diseases from the eye lids to the optic nerve
- Discussion of potential adverse effects of pharmacologic treatments and limitationof side effects in the treatment of ocular disease
- Includes supplementary material: sn.pub/extras
- Includes supplementary material: sn.pub/extras
Part of the book series: Handbook of Experimental Pharmacology (HEP, volume 242)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (15 chapters)
-
Front Matter
-
Back Matter
About this book
Editors and Affiliations
-
Akrivista and Whitecap Biosciences, Mission Viejo, USA
Scott M. Whitcup
-
Illinois Eye and Ear Infirmary, University of Illinois at Chicago College of Medicine, Chicago, USA
Dimitri T. Azar
Bibliographic Information
Book Title: Pharmacologic Therapy of Ocular Disease
Editors: Scott M. Whitcup, Dimitri T. Azar
Series Title: Handbook of Experimental Pharmacology
DOI: https://doi.org/10.1007/978-3-319-58290-0
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer International Publishing AG 2017
Hardcover ISBN: 978-3-319-58288-7Published: 16 June 2017
Softcover ISBN: 978-3-319-86366-5Published: 04 August 2018
eBook ISBN: 978-3-319-58290-0Published: 05 June 2017
Series ISSN: 0171-2004
Series E-ISSN: 1865-0325
Edition Number: 1
Number of Pages: VIII, 394
Topics: Pharmacology/Toxicology, Pharmaceutical Sciences/Technology, Ophthalmology